184 related articles for article (PubMed ID: 24938184)
1. Prostate specific antigen testing is associated with men's psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study.
Flahavan EM; Drummond FJ; Bennett K; Barron TI; Sharp L
BMC Fam Pract; 2014 Jun; 15():121. PubMed ID: 24938184
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study.
Young GJ; Harrison S; Turner EL; Walsh EI; Oliver SE; Ben-Shlomo Y; Evans S; Lane JA; Neal DE; Hamdy FC; Donovan JL; Martin RM; Metcalfe C
BMJ Open; 2017 Oct; 7(10):e017729. PubMed ID: 29084797
[TBL] [Abstract][Full Text] [Related]
3. Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
Avery KN; Metcalfe C; Vedhara K; Lane JA; Davis M; Neal DE; Hamdy FC; Donovan JL; Blazeby JM
Eur Urol; 2012 Oct; 62(4):649-55. PubMed ID: 22244151
[TBL] [Abstract][Full Text] [Related]
4. Uptake of cancer screening services among middle and older ages in Ireland: the role of healthcare eligibility.
Connolly S; Whyte R
Public Health; 2019 Aug; 173():42-47. PubMed ID: 31254676
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
[TBL] [Abstract][Full Text] [Related]
6. Correlates of prostate-specific antigen testing in a large multiethnic cohort.
Haque R; Van Den Eeden SK; Jacobsen SJ; Caan B; Avila CC; Slezak J; Sternfeld B; Loo RK; Quinn VP
Am J Manag Care; 2009 Nov; 15(11):793-9. PubMed ID: 19895183
[TBL] [Abstract][Full Text] [Related]
7. A comparison of US and Australian men's values and preferences for PSA screening.
Howard K; Brenner AT; Lewis C; Sheridan S; Crutchfield T; Hawley S; Nielsen ME; Pignone MP
BMC Health Serv Res; 2013 Oct; 13():388. PubMed ID: 24093428
[TBL] [Abstract][Full Text] [Related]
8. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
[TBL] [Abstract][Full Text] [Related]
9. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
Zanwar P; Lin YL; Kuo YF; Goodwin JS
BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
[TBL] [Abstract][Full Text] [Related]
10. Intention to test for prostate cancer.
Berglund G; Nilsson S; Nordin K
Eur J Cancer; 2005 May; 41(7):990-7. PubMed ID: 15862747
[TBL] [Abstract][Full Text] [Related]
11. The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample.
Kotwal AA; Schumm P; Mohile SG; Dale W
Med Care; 2012 Dec; 50(12):1037-44. PubMed ID: 22955835
[TBL] [Abstract][Full Text] [Related]
12. Disparities Associated with Shared Decision-making in Prostate Cancer Screening.
Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
[TBL] [Abstract][Full Text] [Related]
13. Association of healthcare barriers with prostate-specific antigen screening among African-American and Afro-Caribbean men.
Lee DJ; Consedine NS; Gonzalez JR; Spencer BA
Urology; 2012 Sep; 80(3):556-63. PubMed ID: 22789295
[TBL] [Abstract][Full Text] [Related]
14. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
15. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
[TBL] [Abstract][Full Text] [Related]
16. "Shared decision-making" for prostate cancer screening: Is it a marker of quality preventative healthcare?
Golijanin B; Bhatt V; Homer A; Malshy K; Ochsner A; Wales R; Khaleel S; Mega A; Pareek G; Hyams E
Cancer Epidemiol; 2024 Feb; 88():102492. PubMed ID: 38056246
[TBL] [Abstract][Full Text] [Related]
17. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
[TBL] [Abstract][Full Text] [Related]
18. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.
Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R
BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004
[TBL] [Abstract][Full Text] [Related]
19. GP and patient predictors of PSA screening in Australian general practice.
Gattellari M; Young JM; Ward JE
Fam Pract; 2003 Jun; 20(3):294-303. PubMed ID: 12738699
[TBL] [Abstract][Full Text] [Related]
20. Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.
Drummond FJ; Carsin AE; Sharp L; Comber H
BMC Fam Pract; 2009 Jan; 10():3. PubMed ID: 19138385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
